Denali Therapeutics Inc. (DNLI) Stock Total Returns

Growth of $10,000 chart

2021-06-03 to 2026-06-03
to
$
%
%
Loading chart…

Investment Performance

Final Value
$3,048
Total Return
-69.52%
CAGR
-21.15%
Dividends
$0.00
Yield on Cost
0.00%

Rolling Returns

1-Month (21 Trading Days)
Average-1.10%
Median-1.48%
Best+69.60%
Worst-35.54%
% of Windows Positive45.5%
1-Year (252 Trading Days)
Average-16.03%
Median-25.65%
Best+84.57%
Worst-71.42%
% of Windows Positive23.7%
3-Year (756 Trading Days)
Average-44.69%
Median-44.75%
Best-3.69%
Worst-73.05%
% of Windows Positive0.0%

Risk Metrics

Maximum Drawdown -85.38%
Average Drawdown -65.62%
Drawdown Duration 1235 Trading Days (Unrecovered)
Sortino Ratio -0.11
Calmar Ratio -0.25
CVaR (5%) -8.24%

Yearly Returns

Year Percentage Abs. Return Dividends Taxes Trans. Costs
2026 partial +19.08% (+51.31% ann.) +$1907.93 $0.00 $0.00 $0.00
2025 -18.99% $1898.92 $0.00 $0.00 $0.00
2024 -5.03% $503.27 $0.00 $0.00 $0.00
2023 -22.83% $2283.35 $0.00 $0.00 $0.00
2022 -37.65% $3764.58 $0.00 $0.00 $0.00
2021 -46.75% $4675.26 $0.00 $0.00 $0.00
2020 +380.83% +$38082.67 $0.00 $0.00 $0.00
2019 -15.68% $1568.25 $0.00 $0.00 $0.00
2018 +32.10% +$3209.71 $0.00 $0.00 $0.00
2017 partial -27.09% (-99.59% ann.) $2708.62 $0.00 $0.00 $0.00

Market Regimes

about
Regime Period Percentage Annual Abs. Return Dividends Taxes Trans. Costs
Secular stagnation / QE / low inflation / duration bull partial December 8, 2017 – February 19, 2020 +22.14% +9.53% +$2214.45 $0.00 $0.00 $0.00
Pandemic shock / liquidity crash February 20, 2020 – March 23, 2020 -32.38% -98.85% $3237.79 $0.00 $0.00 $0.00
Policy bazooka / monetary euphoria March 24, 2020 – November 6, 2020 +199.67% +484.70% +$19966.84 $0.00 $0.00 $0.00
Reopening reflation / fiscal boom / supply bottlenecks November 9, 2020 – November 29, 2021 -20.53% -19.59% $2053.40 $0.00 $0.00 $0.00
Inflation shock / duration crash / aggressive tightening November 30, 2021 – November 9, 2022 -41.98% -43.90% $4198.01 $0.00 $0.00 $0.00
Disinflation rebound / AI-led narrow bull / higher-for-longer November 10, 2022 – September 17, 2024 +0.69% +0.37% +$68.92 $0.00 $0.00 $0.00
Disinflationary easing / resilient growth / AI capex under oil-shock test partial September 18, 2024 – June 3, 2026 -36.09% -23.08% $3608.59 $0.00 $0.00 $0.00

Dividend History

Date Per Share Yield %
Total 0 payments
No dividends recorded.

All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.

For each rolling window, returns are calculated at every possible starting point:

return = (value[i] ÷ value[i − windowSize] − 1) × 100

Windows
1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
Statistics
Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.

The series is segmented by calendar year:

return = (endValue ÷ startValue − 1) × 100

startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.

DLTR

CAGR 15.74% Total 9525.88% Final $962,588
1995-03-07 — 2026-06-03
NABL

CAGR -25.59% Total -76.31% Final $2,369
2021-07-19 — 2026-06-03
VIA

CAGR -80.64% Total -69.48% Final $3,052
2025-09-12 — 2026-06-03